Skip to content

Do Hip Injections Improve Short-Term Biomechanical Outcomes In Patients With Hip Pain

Do Hip Injections Improve Short-Term Biomechanical Outcomes In Patients With Hip Pain

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01390103
Enrollment
29
Registered
2011-07-08
Start date
2011-03-31
Completion date
2012-10-31
Last updated
2013-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Pain

Keywords

hip pain

Brief summary

The purpose of this project is to determine the effect of hip injections on hip biomechanics in patients with hip pain.

Interventions

OTHERAssessment following hip injection

Assessment to evaluate the effect of the hip injection on biomechanics.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Osteoarthritis patients with hip pain requiring hip injection * Receiving hip injection * BMI \< 35

Exclusion criteria

* BMI \> 35 * severely impaired intellectual capacity * dementia, or other neurodegenerative diseases that would preclude appropriate cognitive or physical ability to perform study protocol

Design outcomes

Primary

MeasureTime frameDescription
Determine the immediate biomechanical effect in patients that receive a hip injection.The short-term biomechanical effects of the hip will be evaluated within 1 hour of the patient receiving the injection.The biomechanical assessment of gait will consist of walking on a gait mat. The mat is a specialized pressure sensor system. Prior to data collection, each participant will walk across the mat three times for acclimation. The first assessment will include a walk at a self-selected, comfortable pace across the mat, repeated three times. The second assessment will include walking as quickly as possible, also repeated three times.

Secondary

MeasureTime frameDescription
Oswestry Hip Pain Disability QuestionnaireBaseline, Within 1 hour of hip injection, 2 weeks post-injectionOswestry Hip Pain Disability Questionnaire. This a standard, well validated questionnaire to assess disability caused by hip pain. The questionnaire is a 10-item scale, ranging from 0 to 100%, to obtain a score for functional disability caused by hip pain.
Medical Outcomes Study (MOS) Short-Form Health Survey (SF-12)Baseline, Within 1 hour of injection, 2 weeks post-injectionThe SF-12 is a global health assessment questionnaire ranging from 0 to 100%, to score self-experienced health related to quality of life. Items are grouped into two domains from which an overall summary score, a physical component score and a mental component score can be derived. A high score on each of the scales reflects a high level of self-experienced health
10 centimeter Visual Analog Scale (VAS)Baseline, Within 1 hour of injection, 2 weeks post-injectionHip pain is a symptom that affects the overall Quality Of Life. Hip pain intensity will be self-assessed by a 10 cm visual analogue scale with terminal descriptors (anchors of 0 cm = no pain; 10 cm = worst possible pain). The VAS is an accepted outcome measure for chronic pain conditions.
Pain Provocative ManeuversBaseline, Within 1 hour of injection, 2 weeks pos-injectionAll patients currently undergoing hip injections receive a basic physical exam including patient specific provocative maneuvers both before and after the injection. The loss of pain after injection of a local anesthetic is part of the routine treatment algorithm and the results will be correlated with other outcome measures

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026